Sign In
Buy OSUR
$4.00
-0.0500 (-1.23%)
At Close: Aug 10, 2026
OraSure Technologies, Inc. (OSUR) Q2 2026 Earnings Call Transcript
09:44am, Thursday, 06'th Aug 2026
OraSure Technologies, Inc. (OSUR) Q2 2026 Earnings Call Transcript
OraSure Technologies Q2 Earnings Call Highlights
12:04am, Thursday, 06'th Aug 2026
OraSure Technologies NASDAQ: OSUR reported second-quarter revenue of $30.6 million, exceeding its guidance range and rising 9.7% sequentially, as stronger public-health diagnostics demand and growth i
OraSure Announces Second Quarter 2026 Financial Results
04:05pm, Wednesday, 05'th Aug 2026
BETHLEHEM, Pa., Aug. 05, 2026 (GLOBE NEWSWIRE) -- OraSure Technologies, Inc. (Nasdaq: OSUR), a leader in point-of-need and home diagnostic tests and sample management solutions, today announced its fi
OraSure to Announce Second Quarter 2026 Financial Results and Host Earnings Call on August 5th
04:10pm, Wednesday, 22'nd Jul 2026
BETHLEHEM, Pa., July 22, 2026 (GLOBE NEWSWIRE) -- OraSure Technologies, Inc. (NASDAQ: OSUR) announced today that it will report its second quarter 2026 financial results on Wednesday, August 5, 2026,
OraSure Receives Emergency Use Authorization for Second Generation Ebola Test
04:30pm, Tuesday, 21'st Jul 2026
The rapid test detects the Bundibugyo virus associated with the current outbreak and can support the diagnosis of both symptomatic individuals and deceased patients. The rapid test detects the Bundibu
OraSure Technologies, Inc. Announces FDA Clearance that Expands Patient‑Friendly Access to Testing for Sexually Transmitted Infections
08:00am, Thursday, 11'th Jun 2026
BETHLEHEM, Pa., June 11, 2026 (GLOBE NEWSWIRE) -- OraSure Technologies, Inc. (“OraSure”) (NASDAQ: OSUR), a leader in point-of-need and home diagnostic tests and sample management solutions today a
OraSure Technologies, Inc. (OSUR) Q1 2026 Earnings Call Transcript
11:41pm, Wednesday, 06'th May 2026
OraSure Technologies, Inc. (OSUR) Q1 2026 Earnings Call Transcript
OraSure Announces First Quarter 2026 Financial Results
04:05pm, Wednesday, 06'th May 2026
BETHLEHEM, Pa., May 06, 2026 (GLOBE NEWSWIRE) -- OraSure Technologies, Inc. (NASDAQ: OSUR), a leader in point-of-need and home diagnostic tests and sample management solutions, today announced its fin
OraSure to Announce First Quarter 2026 Financial Results and Host Earnings Call on May 6th
04:10pm, Wednesday, 22'nd Apr 2026
BETHLEHEM, Pa., April 22, 2026 (GLOBE NEWSWIRE) -- OraSure Technologies, Inc. (NASDAQ: OSUR) has scheduled its regular earnings conference call covering first quarter 2026 financial results and certai
OraSure Technologies Appoints John D. Bertrand to its Board of Directors
08:10pm, Thursday, 16'th Apr 2026
Enters into Cooperation Agreement with Altai Capital Board to Seek Shareholder Approval for Declassification at the 2026 Annual Meeting BETHLEHEM, Pa., April 16, 2026 (GLOBE NEWSWIRE) -- OraSure Techn
OraSure Technologies (NASDAQ:OSUR) Stock Crosses Above Two Hundred Day Moving Average – Here’s Why
03:43am, Wednesday, 08'th Apr 2026
OraSure Technologies, Inc. (NASDAQ: OSUR - Get Free Report)'s share price crossed above its 200-day moving average during trading on Tuesday. The stock has a 200-day moving average of $2.77 and traded
OraSure Technologies (NASDAQ:OSUR) Stock Crosses Above 200-Day Moving Average – Here’s What Happened
02:10am, Tuesday, 31'st Mar 2026
Shares of OraSure Technologies, Inc. (NASDAQ: OSUR - Get Free Report) crossed above its 200-day moving average during trading on Monday. The stock has a 200-day moving average of $2.78 and traded as h
OraSure Highlights Significant Operational Progress and Value Creation Initiatives Following Letter from Altai Capital
04:52pm, Tuesday, 17'th Mar 2026
Company Has Demonstrated Momentum on Transformation Strategy with Significant Regulatory and Commercial Milestones Approaching in 2026 Highlights Extensive Engagement with Altai Altai Has Rejected All
LOS ANGELES--(BUSINESS WIRE)--Altai Capital Management, L.P. ("Altai"), one of the largest shareholders and the beneficial owners of approximately 5% of the outstanding common stock of OraSure Technol
Exclusive: Altai Capital presses OraSure to sell and give it board seats, letter says
08:02am, Tuesday, 17'th Mar 2026
Activist investor Altai Capital Management called on OraSure Technologies to explore a sale, saying the medical device maker could fetch double its current share price, according to a letter see
